Chronic wasting disease of cervids

Implications of farmed-cervid movements on the transmission of chronic wasting disease

Chronic wasting disease is a transmissible spongiform encephalopathy that affects cervids with a clinical picture of muscle wasting in infected animals. The objective of this study was to quantify movement patterns of farmed cervids in the state of Minnesota as a model for identifying potential disease mitigation points. Time aggregated network analysis was performed on data consisting of 1221 intra-state cervid movements from farms located within Minnesota (n = 432 farms). Intra-state movements accounted for 48.2 % of all documented movements (2578) in Minnesota from 2013 to 2018; the remaining movements were inter-state. Annual networks were sparse in nature with low graph densities (6.9 × 10^-4 - 1.4 × 10^-3) and transitivity (0.06-0.12). Frequency of movements increased significantly (p < 0.05) in the months of September and October before decreasing in November, which coincided with the breeding and hunting seasons. Some of these contacts were as far as 500 km apart. The median length of infection chains for CWD positive farms was estimated to be 5.0 and 6.0 farms in-and out-going infection chains, respectively. A k-test analysis demonstrated that the observed median number of infected farms directly connected to other infected farms was 2.0, which was significantly higher than a fortuitous event (p = 0.002). Movements of cervids between farms were largely unpredictable with very low edge overlap (mean 0.02 %) from year to year, suggesting that persistent commercial relationships among farms were rare. In conclusion, long distance trade movements present a risk for spread of chronic wasting disease in Minnesota. The sparse networks and unpredictable farm contacts could be because cervid production is not as vertically integrated as other species-differentiated and established industries, such as swine or poultry. Our analytical approach can be used to understand chronic wasting disease in other states in the U.S. and North America in general.

Characterization of serotonin following exposure to antibiotics in white-tailed deer

Developing baseline concentrations of serotonin in healthy white-tailed deer will allow for the development of a biomarker using non-invasive sample tissues in sick animals, for example, non-clinical cases of chronic wasting disease. It will also allow some further insight into whether the use of antibiotics as growth promoters (AGP), such as chlortetracycline, is affecting serotonin concentrations in white-tailed deer. Florfenicol and tulathromycin impacts on serotonin concentration changes were also investigated. An analytical method for the detection and confirmation of serotonin, 5-hydroxytryptamine (5-HT), in white-tailed deer tissues was developed and validated. Serum and urine samples were extracted with acetonitrile. Liquid chromatography separation was attained on a Phenomenex C₁₈ column with a Security Guard ULTRA guard column with gradient elution using a mobile phase of 0.1% formic acid in water and 0.1% formic acid in acetonitrile. This methodology was applied to baseline (control), chlortetracycline (CTC) treated, florfenicol treated and tulathromycin treated white-tailed deer serum and urine samples.

Use of faecal volatile organic compound analysis for ante-mortem discrimination between CWD-positive, -negative exposed, and -known negative white-tailed deer (Odocoileus virginianus)

Chronic wasting disease (CWD) is a naturally occurring infectious, fatal, transmissible spongiform encephalopathy of cervids. Currently, disease confirmation relies on post-mortem detection of infectious prions in the medial retropharyngeal lymph nodes or obex in the brain via immunohistochemistry (IHC). Detection of CWD in living animals using this method is impractical, and IHC and other experimental assays are not reliable in detecting low concentrations of prion present in biofluids or faeces. Here, we evaluate the capability of faecal volatile organic compound analysis to discriminate between CWD-positive and -exposed white-tailed deer located at two positive cervid farms, and two groups of CWD-negative deer from two separate disease-free farms.

Current evidence on the transmissibility of chronic wasting disease prions to humans-A systematic review

A number of prion diseases affect humans, including Creutzfeldt-Jakob disease; most of these are due to genetic mutations in the affected individual and occur sporadically, but some result from transmission of prion proteins from external sources. Of the known animal prion diseases, only bovine spongiform encephalopathy prions have been shown to be transmissible from animals to humans under non-experimental conditions. Chronic wasting disease (CWD) is a prion disease that affects cervids (e.g., deer and elk) in North America and isolated populations in Korea and Europe. Systematic review methodology was used to identify, select, critically appraise and analyse data from relevant research. Studies were evaluated for adherence to good conduct based on their study design following the Cochrane collaboration's approach to grading the quality of evidence and the strength of recommendations (GRADE). Twenty-three studies were included after screening 800 citations from the literature search and evaluating 78 full papers. Studies examined the transmissibility of CWD prions to humans using epidemiological study design, in vitro and in vivo experiments. Five epidemiological studies, two studies on macaques and seven studies on humanized transgenic mice provided no evidence to support the possibility of transmission of CWD prions to humans. Ongoing surveillance in the United States and Canada has not documented CWD transmission to humans. However, two studies on squirrel monkeys provided evidence that transmission of CWD prions resulting in prion disease is possible in these monkeys under experimental conditions and seven in vitro experiments provided evidence that CWD prions can convert human prion protein to a misfolded state. Therefore, future discovery of CWD transmission to humans cannot be entirely ruled out on the basis of current studies, particularly in the light of possible decades-long incubation periods for CWD prions in humans. It would be prudent to continue CWD research and epidemiologic surveillance, exercise caution when handling potentially contaminated material and explore CWD management opportunities.